Related Experiment Video
Updated: May 21, 2026
11:01
Examining the Characteristics of Episodic Memory using Event-related Potentials in Patients with Alzheimer's Disease
Published on: August 30, 2011
Destination memory in mild Alzheimer's Disease
Mohamad El Haj1, Virginie Postal, Didier Le Gall
1Laboratoire de Psychologie, Université d'Angers, Angers, France. el.haj@hotmail.fr
Behavioural Neurology
|June 21, 2012
Summary
Destination memory is significantly impaired in Alzheimer Disease (AD). Both AD patients and older adults showed poorer recall than young adults, indicating a decline in remembering who received information.
Area of Science:
- Neuroscience
- Cognitive Psychology
- Gerontology
Background:
- Destination memory, the ability to recall who received specific information, is crucial for social interaction.
- Age-related cognitive decline can affect memory functions, including the ability to track information recipients.
- Alzheimer Disease (AD) is a progressive neurodegenerative disorder known to severely impact memory and cognition.
Purpose of the Study:
- To investigate and compare destination memory performance across three groups: patients with probable mild Alzheimer Disease (AD), healthy older adults, and young adults.
- To determine the extent to which destination memory is impaired in mild AD compared to normal aging.
Main Methods:
- A cohort of 16 individuals with probable mild AD, 16 healthy older adults, and 16 young adults participated.
- Participants engaged in a task requiring them to associate facts with specific pictures.
- A subsequent recall task assessed their ability to remember whether they had previously associated a fact with a particular face.
Main Results:
- Alzheimer Disease patients demonstrated significantly poorer destination recall compared to older adults.
- Healthy older adults exhibited lower destination recall performance than young adults.
- A clear age-related decline in destination memory was observed, with the most pronounced deficit in the AD group.
Conclusions:
- Destination memory is demonstrably impaired in individuals with probable mild Alzheimer Disease.
- The findings highlight a significant decline in the ability to recall information recipients, a key aspect of social cognition, in AD.
- Destination memory deficits represent a notable cognitive challenge in Alzheimer Disease, potentially impacting daily social functioning.
Related Concept Videos
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:30Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.